NEUROLOGY NW LIMITEDActive

Company number 07356142Private limited companyIncorporated 2010
⚠ Confirmation statement overdue. It was due on 17 Oct 2026.

Key figures

£1,418,819-4.0%
Net assets 2025/26
+5.2%
Average annual growth 2019/20–2025/26
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, NEUROLOGY NW LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Total assets1,558,9461,596,8571,619,2711,569,1501,486,160
Total liabilities238,169240,898198,07391,46967,343
Net assets / total equity1,320,7771,355,9591,421,1991,477,6831,418,819
Average number of employees22111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: NEUROLOGY NW LIMITED

Company

NEUROLOGY NW LIMITED is a private limited company registered with Companies House under company number 07356142. It was incorporated on 25 Aug 2010. Its status is active. The registered office is in Stockport (SK12). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Aug 2026); the company files micro-entity accounts. Net assets were £1,418,819, down 4% on the previous year. Total assets were £1,486,160 and total liabilities £67,343. The company had an average of 1 employee. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 May 2028. The next confirmation statement is due by 17 Oct 2026.